309 related articles for article (PubMed ID: 25450672)
21. Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1.
Yang SC; Chang SH; Hsieh PW; Huang YT; Ho CM; Tsai YF; Hwang TL
Free Radic Biol Med; 2017 May; 106():254-269. PubMed ID: 28232203
[TBL] [Abstract][Full Text] [Related]
22. AZ2158 is a more potent formyl peptide receptor 1 inhibitor than the commonly used peptide antagonists in abolishing neutrophil chemotaxis.
Forsman H; Wu Y; Mårtensson J; Björkman L; Granberg KL; Dahlgren C; Sundqvist M
Biochem Pharmacol; 2023 May; 211():115529. PubMed ID: 37004778
[TBL] [Abstract][Full Text] [Related]
23. A neutrophil inhibitory pepducin derived from FPR1 expected to target FPR1 signaling hijacks the closely related FPR2 instead.
Winther M; Gabl M; Welin A; Dahlgren C; Forsman H
FEBS Lett; 2015 Jul; 589(15):1832-9. PubMed ID: 26071379
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, Biological Evaluation, and Molecular Modeling of Aza-Crown Ethers.
Basok SS; Schepetkin IA; Khlebnikov AI; Lutsyuk AF; Kirichenko TI; Kirpotina LN; Pavlovsky VI; Leonov KA; Vishenkova DA; Quinn MT
Molecules; 2021 Apr; 26(8):. PubMed ID: 33921479
[TBL] [Abstract][Full Text] [Related]
25. Randialic acid B and tomentosolic acid block formyl peptide receptor 1 in human neutrophils and attenuate psoriasis-like inflammation in vivo.
Korinek M; Hsieh PS; Chen YL; Hsieh PW; Chang SH; Wu YH; Hwang TL
Biochem Pharmacol; 2021 Aug; 190():114596. PubMed ID: 33964283
[TBL] [Abstract][Full Text] [Related]
26. Tumour necrosis factor (TNF)-alpha primes murine neutrophils when triggered via formyl peptide receptor-related sequence 2, the murine orthologue of human formyl peptide receptor-like 1, through a process involving the type I TNF receptor and subcellular granule mobilization.
Onnheim K; Bylund J; Boulay F; Dahlgren C; Forsman H
Immunology; 2008 Dec; 125(4):591-600. PubMed ID: 18710405
[TBL] [Abstract][Full Text] [Related]
27. Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2.
Khau T; Langenbach SY; Schuliga M; Harris T; Johnstone CN; Anderson RL; Stewart AG
FASEB J; 2011 Feb; 25(2):483-96. PubMed ID: 20930115
[TBL] [Abstract][Full Text] [Related]
28. Propofol inhibits superoxide production, elastase release, and chemotaxis in formyl peptide-activated human neutrophils by blocking formyl peptide receptor 1.
Yang SC; Chung PJ; Ho CM; Kuo CY; Hung MF; Huang YT; Chang WY; Chang YW; Chan KH; Hwang TL
J Immunol; 2013 Jun; 190(12):6511-9. PubMed ID: 23670191
[TBL] [Abstract][Full Text] [Related]
29. Formyl peptide receptor expression in birds.
Panaro MA; Cianciulli A; Lisi S; Sisto M; Acquafredda A; Mitolo V
Immunopharmacol Immunotoxicol; 2007; 29(1):1-16. PubMed ID: 17464763
[TBL] [Abstract][Full Text] [Related]
30. The peptidomimetic Lau-(Lys-βNSpe)
Skovbakke SL; Winther M; Gabl M; Holdfeldt A; Linden S; Wang JM; Dahlgren C; Franzyk H; Forsman H
Biochem Pharmacol; 2016 Nov; 119():56-65. PubMed ID: 27614010
[TBL] [Abstract][Full Text] [Related]
31. A novel nonpeptide ligand for formyl peptide receptor-like 1.
Nanamori M; Cheng X; Mei J; Sang H; Xuan Y; Zhou C; Wang MW; Ye RD
Mol Pharmacol; 2004 Nov; 66(5):1213-22. PubMed ID: 15308762
[TBL] [Abstract][Full Text] [Related]
32. The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis.
Prevete N; Liotti F; Visciano C; Marone G; Melillo RM; de Paulis A
Oncogene; 2015 Jul; 34(29):3826-38. PubMed ID: 25263443
[TBL] [Abstract][Full Text] [Related]
33. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C
Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291
[TBL] [Abstract][Full Text] [Related]
34. Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1.
Khlebnikov AI; Schepetkin IA; Kirpotina LN; Brive L; Dahlgren C; Jutila MA; Quinn MT
J Mol Model; 2012 Jun; 18(6):2831-43. PubMed ID: 22127612
[TBL] [Abstract][Full Text] [Related]
35. Intracellular formyl peptide receptor regulates naïve CD4 T cell migration.
Lee HY; Jeong YS; Lee M; Kweon HS; Huh YH; Park JS; Hwang JE; Kim K; Bae YS
Biochem Biophys Res Commun; 2018 Feb; 497(1):226-232. PubMed ID: 29427663
[TBL] [Abstract][Full Text] [Related]
36. Agonist concentration-dependent changes in FPR1 conformation lead to biased signaling for selective activation of phagocyte functions.
Wang J; Ye RD
Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2201249119. PubMed ID: 35878025
[TBL] [Abstract][Full Text] [Related]
37. Aurantiamide-related dipeptide derivatives are formyl peptide receptor 1 antagonists.
Mastromarino M; Kirpotina LN; Schepetkin IA; Quinn MT; Lacivita E; Leopoldo M
Medchemcomm; 2019 Dec; 10(12):2078-2088. PubMed ID: 32206242
[TBL] [Abstract][Full Text] [Related]
38. Functional expression of formyl peptide receptor family in human NK cells.
Kim SD; Kim JM; Jo SH; Lee HY; Lee SY; Shim JW; Seo SK; Yun J; Bae YS
J Immunol; 2009 Nov; 183(9):5511-7. PubMed ID: 19843937
[TBL] [Abstract][Full Text] [Related]
39. The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis.
Snapkov I; Öqvist CO; Figenschau Y; Kogner P; Johnsen JI; Sveinbjørnsson B
BMC Cancer; 2016 Jul; 16():490. PubMed ID: 27432059
[TBL] [Abstract][Full Text] [Related]
40. The proteolytically stable peptidomimetic Pam-(Lys-βNSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2.
Skovbakke SL; Heegaard PM; Larsen CJ; Franzyk H; Forsman H; Dahlgren C
Biochem Pharmacol; 2015 Jan; 93(2):182-95. PubMed ID: 25462815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
